XDH and ischemic cardiomyopathy: The pro-oxidant activity of XO has been observed [108], and XO from endothelial vasculature has been proposed as the main ROS enzymatic source [93]; accordingly, patients with ischemic cardiomyopathy oxypurinol-induced inhibition of XO had shown improved myocardial contractility [109].